Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh disposes of 242,773 common shares worth USD 377,639.16

NMRA•2026-08-19

Insider transactions reported in mid-August

Neumora Therapeutics Chief Operating and Development Officer Aurora Daljit Singh reported option exercises, stock sales, and trust transactions dated Aug. 17-19, 2026.

Direct holdings ended at 48,750 common shares following the transactions.

Reported sales totaled 156,852 shares at weighted average prices of $1.49 to $1.65.

Sources

Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh disposes of 242,773 common shares worth USD 377,639.16

Sec

Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh disposes of 242,773 common shares worth USD 377,639.16

Insider transactions reported in mid-August

Related News

Don't blame US bond market indigestion on AI debt binge: McGeever

PEDEVCO Executive VP Clark Moore reports PED common share sale worth $129,425.13

Regenerative Medical Technology Group net loss widens to US$ 2.91 million in Q2 FY26; revenue rises to US$ 4.02 million

Sources

Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh disposes of 242,773 common shares worth USD 377,639.16

DigitalOcean CEO Srinivasan Padmanabhan T sells 5,697 shares worth $735,132.67

Universal Safety Products director, 10% owner Milton C. Ault III acquires common shares worth $164,214.06